BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

BioMedix, Inc. Launches Enhanced Non-Invasive Vascular Testing Devices, PADnet® and VEINnet™


12/18/2012 9:26:05 AM

ST. PAUL, Minn., Dec. 18, 2012 /PRNewswire/ -- BioMedix, a leader in healthcare IT designed to help manage disease and optimize medical practices, today introduced exciting technology for non-invasive vascular testing. The next generation of the BioMedix flagship device, PADnet, and the new VEINnet device deliver expanded vascular testing capabilities and added clinical value while remaining remarkably user friendly.

Vascular diseases, including Peripheral Artery Disease (PAD) and Chronic Venous Insufficiency (CVI), affect millions of Americans and can be life-threatening if not detected. PAD involves poor circulation in the limbs due to narrowing of the arteries as a result of plaque buildup and hardening of the arteries (atherosclerosis). PAD increases risk for heart attack, stroke and amputation. CVI is a common cause of leg pain and swelling that occurs when the valves of the veins do not function properly and circulation of blood in the leg veins is impaired. CVI may be an indicator of blood clots in the deep veins of the legs, and can lead to venous hypertension and ulceration.1

PAD and CVI can be treated effectively if detected early. PADnet provides non-invasive testing for PAD in just 15 to 20 minutes and is Doppler enabled to allow external Doppler device input. VEINnet facilitates early detection of CVI and proximal venous obstruction in as little as 15 minutes.

"The next generation PADnet and the new VEINnet represent exciting steps forward in BioMedix vascular testing technology," said David Lerner, BioMedix Vice President of R & D and CTO. "These devices continue to enable greater access to vascular disease testing in non-interventional settings, meaning that more patients with disease can be found before disease progresses to a potentially critical stage."

PADnet detects PAD with Ankle-Brachial Index, Toe-Brachial Index and Pulse Volume Recording capabilities, including Post-Exercise testing and Segmental Pressures testing. VEINnet offers multi-method venous refill tests to identify venous insufficiency and venous outflow testing to help determine the presence of proximal venous obstruction. PADnet and VEINnet support the effective detection of vascular disease, even in patients with advanced disease. The tests are clinically valuable and provide fair financial return with medically-appropriate testing.

The devices send test data to a remote specialist for web-based interpretation, providing a platform that encourages collaborative care and improved outcomes. VEINnet and PADnet systems seamlessly integrate with the complete suite of BioMedix disease management and practice optimization products and services, creating a comprehensive solution.

"We are thrilled to introduce new technology with the power to expand the collaborative care network of healthcare professionals who are working to save limbs and lives through coordinated patient care," said John Romans, BioMedix President & CEO.

About BioMedix

BioMedix is a leader in healthcare IT designed to build and support community-based collaborative healthcare networks. BioMedix solutions coordinate the identification, treatment and management of patients with vascular disease while optimizing provider resources with cloud- and premise-based tools and integrated services. For more information about BioMedix, PADnet and VEINnet, call 877-854-0014 or visit www.BioMedix.com.

1. Vascular Disease Foundation. (2012.) http://vasculardisease.org. / Reference: ML-043, ML-188

SOURCE BioMedix


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->